Home LiteratureArticle Details
PMID: 15016844 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Journal of virology ·Vol. 78 ·No. 7 ·2004-04-00 ·Pages 3233-43

Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM, HIVNET 028 Study Team

Abstract

An understanding of the relationship between the breadth and magnitude of T-cell epitope responses and viral loads is important for the design of effective vaccines. For this study, we screened a cohort of 46 subtype C human immunodeficiency virus type 1 (HIV-1)-infected individuals for T-cell responses against a panel of peptides corresponding to the complete subtype C genome. We used a gamma interferon ELISPOT assay to explore the hypothesis that patterns of T-cell responses across the expressed HIV-1 genome correlate with viral control. The estimated median time from seroconversion to response for the cohort was 13 months, and the order of cumulative T-cell responses against HIV proteins was as follows: Nef > Gag > Pol > Env > Vif > Rev > Vpr > Tat > Vpu. Nef was the most intensely targeted protein, with 97.5% of the epitopes being clustered within 119 amino acids, constituting almost one-third of the responses across the expressed genome. The second most targeted region was p24, comprising 17% of the responses. There was no correlation between viral load and the breadth of responses, but there was a weak positive correlation (r = 0.297; P = 0.034) between viral load and the total magnitude of responses, implying that the magnitude of T-cell recognition did not contribute to viral control. When hierarchical patterns of recognition were correlated with the viral load, preferential targeting of Gag was significantly (r = 0.445; P = 0.0025) associated with viral control. These data suggest that preferential targeting of Gag epitopes, rather than the breadth or magnitude of the response across the genome, may be an important marker of immune efficacy. These data have significance for the design of vaccines and for interpretation of vaccine-induced responses.

MeSH Terms
Amino Acid Sequence CD8-Positive T-Lymphocytes/immunology Epitopes/chemistry,immunology HIV Antigens/chemistry,immunology HIV Infections/immunology,virology HIV-1/classification,immunology,metabolism,physiology Humans Molecular Sequence Data Viral Load Viremia/immunology,virology
Chemicals
Epitopes HIV Antigens
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Masemola Agatha
National Institute for Communicable Diseases, Johannesburg, South Africa.
Mashishi Tumelo
Khoury Greg
Mohube Phineas
Mokgotho Pauline
Vardas Efthyia
Colvin Mark
Zijenah Lynn
Katzenstein David
Musonda Rosemary
Allen Susan
Kumwenda Newton
Taha Taha
Gray Glenda
McIntyre James
Karim Salim Abdool
Sheppard Haynes W
Gray Clive M
HIVNET 028 Study Team
References (48)
48 references, click to expand
  1. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.
    J Virol. 2003 Jul;77(13):7330-40 PMID: 12805431
  2. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    J Virol. 2003 Jun;77(12):6867-78 PMID: 12768006
  3. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  4. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    J Exp Med. 1995 Apr 1;181(4):1365-72 PMID: 7699324
  5. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.
    J Virol. 1995 Sep;69(9):5838-42 PMID: 7637030
  6. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    J Immunol. 1996 Apr 1;156(7):2616-23 PMID: 8786327
  7. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.
    AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92 PMID: 8743084
  8. Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda.
    J Gen Virol. 1997 Feb;78 ( Pt 2):393-400 PMID: 9018062
  9. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.
    AIDS. 1997 Jan;11(1):81-7 PMID: 9110079
  10. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.
    J Virol. 1997 Nov;71(11):8908-11 PMID: 9343257
  11. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades.
    J Virol. 1998 Mar;72(3):2439-48 PMID: 9499105
  12. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  13. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    AIDS. 1998 Apr 16;12(6):571-9 PMID: 9583596
  14. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    AIDS Res Hum Retroviruses. 1998 Jul 20;14(11):925-37 PMID: 9686639
  15. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.
    J Virol. 1999 Jan;73(1):436-43 PMID: 9847349
  16. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  17. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  18. A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations.
    AIDS Res Hum Retroviruses. 1999 Mar 1;15(4):395-8 PMID: 10082124
  19. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
    J Immunol. 1999 May 1;162(9):5127-33 PMID: 10227983
  20. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28 PMID: 10480635
  21. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
    J Virol. 2000 Mar;74(6):2502-9 PMID: 10684264
  22. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.
    AIDS. 2000 Feb 18;14(3):225-33 PMID: 10716497
  23. Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    J Exp Med. 2000 Jun 5;191(11):1921-31 PMID: 10839807
  24. High HIV incidence and prevalence among young women in rural South Africa: developing a cohort for intervention trials.
    J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):405-9 PMID: 10866233
  25. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Science. 2000 Oct 20;290(5491):486-92 PMID: 11039923
  26. Comparison of Vif sequences from diverse geographical isolates of HIV type 1 and SIV(cpz) identifies substitutions common to subtype C isolates and extensive variation in a proposed nuclear transport inhibition signal.
    AIDS Res Hum Retroviruses. 2001 Jan 20;17(2):169-77 PMID: 11177396
  27. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.
    Hum Immunol. 2001 Feb;62(2):146-56 PMID: 11182225
  28. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Science. 2001 Apr 6;292(5514):69-74 PMID: 11393868
  29. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
    J Virol. 2001 Jun;75(11):5151-8 PMID: 11333896
  30. Molecular characterization of HIV type 1 vpu genes from mothers and infants after perinatal transmission.
    AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1089-98 PMID: 11485627
  31. Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa.
    AIDS Res Hum Retroviruses. 2001 Nov 1;17(16):1533-47 PMID: 11709098
  32. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    J Virol. 2001 Dec;75(24):11983-91 PMID: 11711588
  33. Conserved domains of subtype C nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions.
    AIDS Res Hum Retroviruses. 2001 Nov 20;17(17):1681-7 PMID: 11779357
  34. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.
    J Immunol Methods. 2002 Feb 1;260(1-2):157-72 PMID: 11792386
  35. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Nature. 2002 Jan 17;415(6869):331-5 PMID: 11797011
  36. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.
    J Virol. 2002 Mar;76(5):2298-305 PMID: 11836408
  37. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    J Virol. 2002 May;76(10):4971-86 PMID: 11967314
  38. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
    J Virol. 2002 Jun;76(11):5435-51 PMID: 11991972
  39. HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate.
    AIDS. 2002 Oct 18;16(15):2085-7 PMID: 12370511
  40. The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.
    Clin Chem Lab Med. 2002 Sep;40(9):903-10 PMID: 12435107
  41. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
    J Virol. 2002 Dec;76(24):12414-22 PMID: 12438567
  42. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    J Infect Dis. 2002 Dec 1;186(11):1589-96 PMID: 12447734
  43. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.
    AIDS. 2002 Dec 6;16(18):2399-407 PMID: 12461413
  44. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.
    J Virol. 2003 Jan;77(2):882-90 PMID: 12502804
  45. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  46. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.
    AIDS Res Hum Retroviruses. 2003 Feb;19(2):133-44 PMID: 12639249
  47. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    J Immunol Methods. 2003 Apr 1;275(1-2):19-29 PMID: 12667667
  48. HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloureds and South African Caucasoids.
    Tissue Antigens. 1988 Mar;31(3):109-25 PMID: 3376097
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-04-00
Pages
3233-43
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC371059
Subset
IM
Grants
NIAID NIH HHS · N01-AI-45202 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]